Cancer Clinical Trial Becomes Futile
Sometimes clinical trials have to be stopped because the therapy being tested does more harm than good. This is what happened in recent esophageal cancer study.
FDA approves Erbitux to treat late-stage head and neck cancer
The U.S. Food and Drug Administration today approved Erbitux ( cetuximab ) for use with chemotherapy to treat patients with late-stage (metastatic) head and neck cancer.